Educational Symposium
In, Out, and In Between: Potassium Homeostasis in an Age of Treatment Options
October 22, 2026 | 12:45 PM - 01:45 PM
Location: TBD Room, Hyatt Regency Denver
Session Description
Potassium homeostasis is an essential component of kidney function, and hyperkalemia is common in individuals with declining kidney function. Hyperkalemia poses clinical challenges because it can affect dietary and medication options in patients with CKD and cardiac dysfunction and may lead to withdrawal of agents that are otherwise beneficial. A clear understanding of both renal and extrarenal potassium homeostasis can help providers navigate complex clinical care.
This symposium reviews extrarenal potassium homeostasis and the management of hyperkalemia in patients with CKD and heart failure and discusses management to optimize guideline-directed medical therapy for these conditions while allowing for healthy, potassium-containing diets.
Seating is limited and available on a first-come, first-served basis to fully paid Annual Meeting participants. Doors open approximately 15 minutes prior to each symposium. When a room reaches capacity, ASN will shut down access to the room. No other participants will be allowed to enter the room, regardless of the number of participants who exit the room during the activity.
Support is provided by an educational grant from AstraZeneca.
Learning Objective(s)
- Describe the essential role of the extrarenal system in potassium homeostasis
- Formulate strategies to continue RAAS blockade in patients with CKD
Learning Pathway(s)
- Fluid‚ Electrolyte‚ and Acid-Base Disorders
- Hypertension and Cardiorenal Disorders
Moderator
Presentations
- Introduction
12:45 PM - 12:55 PM
- What's the Gut Got to Do with It? Extrarenal Potassium Homeostasis
12:55 PM - 01:15 PM
- Love Your K and Eat It Too: Strategies to Continue Healthy Dietary Potassium and Guideline-Directed Medical Therapy in CKD and Heart Failure with New Treatment Options
01:15 PM - 01:35 PM
- Q&A
01:35 PM - 01:45 PM